AAC statement on NAATP lawsuit

As the National Association of Addiction Treatment Providers (NAATP) was beginning its annual leadership meeting May 6, American Addiction Centers sued the organization in federal court (see “AAC sues NAATP for defamation,” ADAW, May 13, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32362 ). We wanted to provide further information on the lawsuit (which we linked to in our story last week). Below is a statement provided exclusively to ADAW by AAC May 15.     

‘Hogwash’: Addiction Policy Foundation on opioid bill reports

Last week, as the Senate headed toward a vote on the opioid package, the Addiction Policy Forum was weathering an attack in the form of almost identical stories in Congressional Quarterly and Politico that said Democrats were opposed to a provision in the bill that favors the advocacy organization. According to both reports, which came out Sept. 5, Democrats objected to the language that would give $10 million a year for five years to an advocacy organization, language that would apply only to the Addiction Policy Forum. The unnamed Democrat staffers, according to the stories, pinned their criticism on the fact that the Addiction Policy Forum receives pharmaceutical funding, something the organization itself announced last December (see ADAW, Jan. 8) but created a minor ruckus after protesters from Minnesota accused the group of a conflict of interest in a story published in The New York Times (see ADAW, Feb. 19, 2018).     

NAATP annual meeting: Measure what you're doing

Last week's annual leadership meeting of the National Association of Addiction Treatment Providers (NAATP) focused on the quality assurance guidebook coming out from the organization (see “NAATP releases draft guidebook for residential treatment providers,” ADAW, April 22, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32334 ). It culminated with a visit to Capitol Hill (see story, p. 3).     

NAATP keeps focus on parity

We need to move beyond the principle of parity into the practice of parity.” These words from Mark Dunn, director of public policy for the National Association of Addiction Treatment Providers (NAATP), in an interview with ADAW last week are a sign of the frustration with how parity — the Mental Health Parity and Addiction Equity Act (MHPAEA), which guarantees that substance use disorders (SUDs) will be treated no differently from medical and surgical claims in the world of reimbursement — has been a real‐world disappointment to patients and providers alike.     

NAATP releases 3‐year pilot outcomes report

Last week, the National Association of Addiction Treatment Providers (NAATP) released the results of its three‐year Outcomes Pilot Program, in which eight pilot sites tested out a method for a standardized outcomes tracking tool. The project was a success, said NAATP Executive Director Marvin Ventrell on March 12. The project resulted in the Outcomes Measurement Toolkit: The Addiction Treatment Provider Guide to Standardized Outcomes Measurement, which NAATP members can start using now.     

Fiellin: Keep the prescriber training for buprenorphine

It seems that almost everyone wants to deregulate buprenorphine for opioid use disorder (OUD) — with proposed legislation focused on getting rid of the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver altogether (see ADAW, Oct. 11, “Bill to deregulate buprenorphine raises concerns among OTPs,” https://onlinelibrary.wiley.com/doi/10.1002/adaw.32510 ).     

NAATP to court: AAC doesn't have a case

Citing “actions that it had every right to take, statements of opinion it had every right to make, and the actions and the conduct of third parties” for which it had no control or responsibility, the National Association of Addiction Treatment Providers (NAATP) filed a motion to dismiss the complaint against it by American Addiction Centers (AAC) filed in May (see ADAW, May 13, May 20).     

Table of Contents

Addiction Medication Marketplace: Opportunities for Drug Developers New SAMHSA Administrator Says Addiction Field not Secondary to MH Prospects Seem Promising for addictiona's Inclusion in Parity Bills Co‐Dependent No More celebrates 20th Anniversary Mental Health vs. Addiction Expenditures Briefly Noted Resources Coming up     

Table of Contents

Full Court Press for Addiction Field on Capitol Hill TC Programs See Benets of Offering Dental Services Access to HBO's Addiction Tobacco Up for FDA Regulation; GAO on State Use Funds Final NJ OIG Report Blasts Addiction Treatment Provider Group Briefly Noted Resources Call for Applications Names in the News Coming up     

Table of Contents

Public Opinion Poll Shows Deep‐Seated Conflict About Addiction as a Disease Internet Addiction Gains Attention as It Intersects with Other Problems Poll Highlights Do You Believe That Addiction Is — or Is Not — a Disease? Factors in Family Member's Drug or Alcohol Addiction GAO Recommends Monitoring Funds Made to Faith‐Based Organizations What Is an FBO? Substance Abuse Counseling Written into Federal Disaster Response Bill Plan for Disaster New CASA Survey Finds Most Parents Don't Know Teens Are Drinking or Using Drugs Briefly Noted Resources Grants and Funding Coming Up     

CCAPP: Number of deaths from untreated addiction may rival those from COVID‐19

In a far‐reaching clarion call for attention to addiction in the midst of the COVID‐19 pandemic, Pete Nielsen, CEO of the California Consortium of Addiction Professionals and Programs (CCAPP), urges policymakers to recognize that the isolation required in shelter‐in‐place will fuel even more deaths from alcohol, drugs and suicide. In The Disease of Addiction Thrives on Isolation, released this month, Nielsen warns that these deaths were already “on track to break records in the number of victims in our state this year,” and goes on to say that those “who survive this year will face a second wave of death due to tobacco related diseases and or relapse to drug of choice unless tobacco is routinely treated in substance use disorder.”     

Letter to the Editor

In “COMBINE follow‐up: Some heavy use of alcohol compatible with recovery” (see ADAW, Aug. 17, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32806 ), we wrote about a study by Katie Witkiewitz, Ph.D., published in Alcoholism: Clinical and Experimental Research, showing that some people can be in recovery but still drink heavily. We received the following commentary from Annie Peters, Ph.D., director of research and education at the National Association of Addiction Treatment Providers (NAATP).     

Table of Contents

Off‐Label Use of Buprenorphine for Pain Worries Officials Growing Number of Programs Add Legitimacy to Sex Addiction Treatment Painkillers, Tranquilizers Account for Rise in Drug Use by Troops Addiction Drug Market ‘Underexploited,’ Should Focus on Cure, Says Report CAARR Responds to From the Field Article on Calif. Licensing Bill Briefly Noted State News Call for Applications Coming up     

Parity getting worse,not better: Milliman report

Medical and behavioral (addiction and mental health) care are further apart now than they were two years ago, according to a study published by Milliman Inc. last week. The report, commissioned by the Bowman Family Foundation, shows that the gap for employees and their families between mental/addiction care and medical/surgical care is widening. The report, Addiction and Mental Health vs. Physical Health: Widening Disparities in Network Use and Provider Reimbursement, is based on actual claim data in 50 states for 37 million employees and their dependents.     

CARF and ASAM award first 7 level‐of‐care certifications

Under the pilot for its new certification program for substance use disorder treatment, the American Society of Addiction Medicine (ASAM) has awarded the first seven certifcaitions. The ASAM level‐of‐care certification was created in partnership with CARF International and announced earlier this year (see “CARF adds OBOT accreditation and ASAM certification,” ADAW, Feb. 4, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32246 ).     

DEA allows buprenorphine inductions based on telephone only

Last week, the Drug Enforcement Administration (DEA) said opioid treatment programs (OTPs) and Drug Addiction Treatment Act (DATA)–waived prescribers can treat new patients with buprenorphine based on a telephone call only. The Controlled Substances Act (CSA), enforced by the DEA, requires all new patients being treated with controlled substances to have an in‐person — or, for now, telemedicine — physical exam. Now, however, because of the coexisting COVID‐19 pandemic and opioid overdose crisis, the DEA has dropped this requirement. This follows the decision of the Substance Abuse and Mental Health Services Administration (SAMHSA) to allow exemptions from the OTP take‐home regulations allowing stable patients to be given 14 or 28 days of methadone doses, instead of coming in more frequently (see DEA, SAMHSA relax OTP/OBOT regulations due to COVID‐19, ADAW March 23, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32664 ).     

Membership doubles,and NAATP plans more on ethics and outcomes for 2019

The National Association of Addiction Treatment Providers (NAATP) has culled its membership, removing members who don't comply with its ethics guidelines — mainly for marketing purposes. But rather than reducing its total numbers, this move has doubled membership, from 450 in the fall of 2015 to more than 900, NAATP Executive Director Marvin Ventrell told ADAW last week.     

Sublocade improves abstinence and quality of life outcomes

Treatment with injectable subcutaneous buprenorphine (Sublocade) over a course of a year resulted in better abstinence and quality of life, according to a study by Walter Ling and colleagues published in the current issue of the Journal of Addiction Medicine.     

NAATP guidebook not only for residential care

The National Association of Addiction Treatment Providers (NAATP) has released its draft guidebook for minimum standards for members (see ADAW, April 22, https://onlinelibrary.wiley.com/doi/10.1002/adaw.32334 ). NAATP is not only for residential treatment providers, however. “Our position at NAATP is that we are a membership association for providers along the entire continuum and that, while residential holds an important place in our work and is our historical foundation, our membership is in no way limited to residential,” NAATP Executive Director Marvin Ventrell told ADAW last week. “Even apart from our membership, we intend our resources, including ethics and the guidebook, to reach and guide the entire continuum. It is true that some of the guidelines have application more or less relative to type of care, but as a whole it should be viewed as a provider guide, not just a residential provider guide.” We regret any confusion. The field — and prominent organizations within it — is changing.     

Behavioural Addictions in Adolescents and Young Adults: Results from a Prevalence Study

Our study aims to assess the prevalence of behavioural addictions in an adolescent population, evaluating the effects of gender and age, and to assess the correlations among different behavioural addictions. 2853 high school students were assessed in order to evaluate the prevalence of behavioural addictions such as Pathological Gambling (PG), Compulsive Buying (CB), Exercise Addiction (EA), Internet Addiction (IA), and Work Addiction (WA), in a population of Italian adolescents. The South Oaks Gambling Screen-Revised Adolescent (SOGS-RA), the Compulsive Buying Scale (CBS), the Exercise Addiction Inventory (EAI), the Internet Addiction Test (IAT), and the Work Addiction Risk Test (WART), were compiled anonymously by the students. Overall prevalence was 7.0% for PG, 11.3% for CB, 1.2% for IA, 7.6% for WA, 8.5% for EA. PG and EA were more common among boys, while gender had no effect on the other conditions. CB was more common among younger (<18 years old) students. The scores of all of these scales were significantly correlated. The strong correlation among different addictive behaviours is in line with the hypothesis of a common psychopathological dimension underlying these phenomena. Further studies are needed to assess personality traits and other clinical disorders associated with these problems behaviours.